Menu
Back to User profile » Dr Norbert Feigler
Papers published by Dr Norbert Feigler:
Risk of Death and Cardiovascular Events Following an Exacerbation of COPD: The EXACOS-CV US Study
Daniels K, Lanes S, Tave A, Pollack MF, Mannino DM, Criner G, Neikirk A, Rhodes K, Feigler N, Nordon C
International Journal of Chronic Obstructive Pulmonary Disease 2024, 19:225-241
Published Date: 18 January 2024
Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study
Strange C, Tkacz J, Schinkel J, Lewing B, Agatep B, Swisher S, Patel S, Edwards D, Touchette DR, Portillo E, Feigler N, Pollack M
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:2245-2256
Published Date: 12 October 2023
A 4-Year Retrospective Claims Analysis of Oral Corticosteroid Use and Health Conditions in Newly Diagnosed Medicare FFS Patients with COPD
Bazell C, Pollack M, Comellas AP, Sethi S, Alston M, Pyenson B, Hansen D, Caplen M, Staresinic A, Styczynski J, Feigler N
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:2635-2652
Published Date: 17 October 2022
Relationship of COPD Exacerbation Severity and Frequency on Risks for Future Events and Economic Burden in the Medicare Fee-For-Service Population
Sethi S, Make BJ, Robinson SB, Kumar S, Pollack M, Moretz C, Dreyfus J, Xi A, Powell D, Feigler N
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:593-608
Published Date: 20 March 2022
PRIMUS – Prompt Initiation of Maintenance Therapy in the US: A Real-World Analysis of Clinical and Economic Outcomes Among Patients Initiating Triple Therapy Following a COPD Exacerbation
Tkacz J, Evans KA, Touchette DR, Portillo E, Strange C, Staresinic A, Feigler N, Patel S, Pollack M
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:329-342
Published Date: 10 February 2022